A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria

Clinical trial NCT07545681 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07545681
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malaria, Falciparum

Start date: 2026-07-28
Primary completion: 2027-07-29
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.